Specifically, the VLA-4—VCAM1 interaction triggers the NF-κB signaling pathway in MM-MSCs and the transcription and secretion of IL-6, a major MM cell growth factor [5]. This evidence concerns the gene IL6 and Miyoshi myopathy.